{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:52Z","timestamp":1770824332004,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143328"],"award-info":[{"award-number":["FDN-143328"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40264-021-01128-1","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T04:02:41Z","timestamp":1635480161000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study"],"prefix":"10.1007","volume":"45","author":[{"given":"Julie","family":"Rouette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Barkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-3556","authenticated-orcid":false,"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"12","key":"1128_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284\u2013309.","journal-title":"J Hypertens"},{"issue":"17","key":"1128_CR2","first-page":"e426","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426\u201383.","journal-title":"Circulation"},{"issue":"2","key":"1128_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou FF, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354(2):131\u201340.","journal-title":"N Engl J Med"},{"issue":"22","key":"1128_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.109.192663","volume":"120","author":"FG Kushner","year":"2009","unstructured":"Kushner FG, et al. 2009 focused updates: ACC\/AHA Guidelines for the management of patients with ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC\/AHA\/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120(22):2271\u2013306.","journal-title":"Circulation"},{"issue":"6","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, et al. 2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u201361.","journal-title":"Circulation"},{"issue":"4","key":"1128_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2020.20317","volume":"325","author":"MA Mederos","year":"2021","unstructured":"Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382\u201390.","journal-title":"JAMA"},{"issue":"1","key":"1128_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","volume":"156","author":"AF Peery","year":"2019","unstructured":"Peery AF, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254-272 e11.","journal-title":"Gastroenterology"},{"key":"1128_CR8","doi-asserted-by":"publisher","first-page":"g4859","DOI":"10.1136\/bmj.g4859","volume":"349","author":"CD Johnson","year":"2014","unstructured":"Johnson CD, Besselink MG, Carter R. Acute pancreatitis. BMJ. 2014;349:g4859.","journal-title":"BMJ"},{"issue":"7","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annepidem.2007.02.002","volume":"17","author":"PJ Fagenholz","year":"2007","unstructured":"Fagenholz PJ, et al. Increasing United States hospital admissions for acute pancreatitis, 1988\u20132003. Ann Epidemiol. 2007;17(7):491\u20137.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"1128_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/j.gastro.2010.06.010","volume":"139","author":"MS Petrov","year":"2010","unstructured":"Petrov MS, et al. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813\u201320.","journal-title":"Gastroenterology"},{"issue":"3","key":"1128_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.hpb.2018.08.003","volume":"21","author":"MB Zilio","year":"2019","unstructured":"Zilio MB, et al. A systematic review and meta-analysis of the aetiology of acute pancreatitis. HPB (Oxford). 2019;21(3):259\u201367.","journal-title":"HPB (Oxford)"},{"issue":"20","key":"1128_CR12","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMra1505202","volume":"375","author":"CE Forsmark","year":"2016","unstructured":"Forsmark CE, Vege SS, Wilcox CM. Acute Pancreatitis. N Engl J Med. 2016;375(20):1972\u201381.","journal-title":"N Engl J Med"},{"issue":"4","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"e0231883","DOI":"10.1371\/journal.pone.0231883","volume":"15","author":"D Wolfe","year":"2020","unstructured":"Wolfe D, et al. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations. PLoS ONE. 2020;15(4):e0231883.","journal-title":"PLoS ONE"},{"issue":"7","key":"1128_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1365-2036.2003.01485.x","volume":"17","author":"RJ Lancashire","year":"2003","unstructured":"Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17(7):887\u201393.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7\u20138","key":"1128_CR15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1345\/aph.1C270","volume":"37","author":"RM Cheng","year":"2003","unstructured":"Cheng RM, et al. Association between ACE inhibitors and acute pancreatitis in the elderly. Ann Pharmacother. 2003;37(7\u20138):994\u20138.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"1128_CR16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1080\/00365520600761676","volume":"41","author":"IA Eland","year":"2006","unstructured":"Eland IA, et al. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol. 2006;41(12):1484\u201390.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"1128_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/apt.12461","volume":"38","author":"A Douros","year":"2013","unstructured":"Douros A, et al. Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases. Aliment Pharmacol Ther. 2013;38(7):825\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"1128_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/pds.4179","volume":"26","author":"J Kuoppala","year":"2017","unstructured":"Kuoppala J, et al. ACE inhibitors and the risk of acute pancreatitis-a population-based case-control study. Pharmacoepidemiol Drug Saf. 2017;26(7):853\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1128_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12876-017-0595-8","volume":"17","author":"TS Bexelius","year":"2017","unstructured":"Bexelius TS, et al. Angiotensin II receptor blockers and risk of acute pancreatitis\u2014a population based case-control study in Sweden. BMC Gastroenterol. 2017;17(1):36.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"1128_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1159\/000225906","volume":"9","author":"T Sjoberg Bexelius","year":"2009","unstructured":"Sjoberg Bexelius T, Garcia Rodriguez LA, Lindblad M. Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology. 2009;9(6):786\u201392.","journal-title":"Pancreatology"},{"issue":"2","key":"1128_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ejhpharm-2015-000840","volume":"24","author":"SW Lai","year":"2017","unstructured":"Lai SW, et al. No association between losartan use and acute pancreatitis in hypertensive patients. Eur J Hosp Pharm. 2017;24(2):120\u20133.","journal-title":"Eur J Hosp Pharm"},{"issue":"8","key":"1128_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1398-9995.2007.01427.x","volume":"62","author":"M Bas","year":"2007","unstructured":"Bas M, et al. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842\u201356.","journal-title":"Allergy"},{"issue":"1","key":"1128_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bjp.0704462","volume":"135","author":"M Hirata","year":"2002","unstructured":"Hirata M, et al. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. Br J Pharmacol. 2002;135(1):29\u201336.","journal-title":"Br J Pharmacol"},{"issue":"9","key":"1128_CR24","doi-asserted-by":"publisher","first-page":"e003389","DOI":"10.1136\/bmjopen-2013-003389","volume":"3","author":"K Bhaskaran","year":"2013","unstructured":"Bhaskaran K, et al. Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2013;3(9):e003389.","journal-title":"BMJ Open"},{"issue":"4","key":"1128_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/pubmed\/fdt116","volume":"36","author":"R Mathur","year":"2014","unstructured":"Mathur R, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf). 2014;36(4):684\u201392.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"1128_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1128_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1128_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ije\/dyx015","volume":"46","author":"A Herbert","year":"2017","unstructured":"Herbert A, et al. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol. 2017;46(4):1093\u20131093i.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1128_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551\u201361.","journal-title":"Stat Med"},{"issue":"8","key":"1128_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pds.3386","volume":"22","author":"CD Mack","year":"2013","unstructured":"Mack CD, et al. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf. 2013;22(8):810\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1128_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","volume":"14","author":"T Sato","year":"2003","unstructured":"Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003;14(6):680\u20136.","journal-title":"Epidemiology"},{"issue":"1","key":"1128_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jclinepi.2011.04.009","volume":"65","author":"D Suissa","year":"2012","unstructured":"Suissa D, et al. Number needed to treat is incorrect without proper time-related considerations. J Clin Epidemiol. 2012;65(1):42\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"19","key":"1128_CR33","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJM198805123181914","volume":"318","author":"P Tilkemeier","year":"1988","unstructured":"Tilkemeier P, Thompson PD. Acute pancreatitis possibly related to enalapril. N Engl J Med. 1988;318(19):1275\u20136.","journal-title":"N Engl J Med"},{"issue":"9","key":"1128_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915\u201320.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1128_CR35","doi-asserted-by":"publisher","first-page":"e1921618","DOI":"10.1001\/jamanetworkopen.2019.21618","volume":"3","author":"J Wei","year":"2020","unstructured":"Wei J, et al. Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis. JAMA Netw Open. 2020;3(2):e1921618.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"1128_CR36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1001\/jamaneurol.2020.2499","volume":"77","author":"D Santos","year":"2020","unstructured":"Santos D, Dhamoon MS. Trends in antihypertensive medication use among individuals with a history of stroke and hypertension, 2005 to 2016. JAMA Neurol. 2020;77(11):1382\u20139.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1128_CR37","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","volume":"75","author":"CG Derington","year":"2020","unstructured":"Derington CG, et al. Trends in antihypertensive medication monotherapy and combination use among US adults, national health and nutrition examination survey 2005\u20132016. Hypertension. 2020;75(4):973\u201381.","journal-title":"Hypertension"},{"issue":"1","key":"1128_CR38","first-page":"77","volume":"21","author":"T Kaurich","year":"2008","unstructured":"Kaurich T. Drug-induced acute pancreatitis. Proc (Bayl Univ Med Cent). 2008;21(1):77\u201381.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"3","key":"1128_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000028355","volume":"60","author":"T Griesbacher","year":"2000","unstructured":"Griesbacher T. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. Pharmacology. 2000;60(3):113\u201320.","journal-title":"Pharmacology"},{"issue":"12","key":"1128_CR40","first-page":"001956","volume":"7","author":"MS Hussain","year":"2020","unstructured":"Hussain MS, et al. Angiotensin-Converting Enzyme (ACE) Inhibitors and Pancreatitis: A Potential Dose-dependent Relationship. Eur J Case Rep Intern Med. 2020;7(12):001956.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"1","key":"1128_CR41","first-page":"45","volume":"15","author":"MR Jones","year":"2015","unstructured":"Jones MR, et al. Drug-induced acute pancreatitis: a review. Ochsner J. 2015;15(1):45\u201351.","journal-title":"Ochsner J"},{"issue":"1","key":"1128_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/jpet.103.053322","volume":"307","author":"T Yamada","year":"2003","unstructured":"Yamada T, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther. 2003;307(1):17\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"1128_CR43","doi-asserted-by":"publisher","first-page":"l5310","DOI":"10.1136\/bmj.l5310","volume":"367","author":"RJ Boffa","year":"2019","unstructured":"Boffa RJ, et al. Hypertension in adults: summary of updated NICE guidance. BMJ. 2019;367:l5310.","journal-title":"BMJ"},{"issue":"658","key":"1128_CR44","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.3399\/bjgp17X690461","volume":"67","author":"N Mejzner","year":"2017","unstructured":"Mejzner N, et al. Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England. Br J Gen Pract. 2017;67(658):e306\u201313.","journal-title":"Br J Gen Pract"},{"issue":"11","key":"1128_CR45","doi-asserted-by":"publisher","first-page":"e031537","DOI":"10.1136\/bmjopen-2019-031537","volume":"9","author":"K Mansfield","year":"2019","unstructured":"Mansfield K, et al. Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study. BMJ Open. 2019;9(11):e031537.","journal-title":"BMJ Open"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-021-01128-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:46:04Z","timestamp":1650282364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-021-01128-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s40264-021-01128-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"14 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by a Foundation Scheme grant from the Canadian Institutes of Health Research (FDN-143328). JR is the recipient of a Doctoral Award from the Canadian Institutes of Health Research (FRN-152254) and a Doctoral Award from the <i>Fonds de Recherche du Qu\u00e9bec- Sant\u00e9<\/i>. EGM holds a Chercheur-Clinicien Junior 1 award from the <i>Fonds de Recherche du Qu\u00e9bec- Sant\u00e9<\/i>. LA holds a Chercheur-Boursier Senior Award from the <i>Fonds de Recherche du Qu\u00e9bec - Sant\u00e9<\/i> and is the recipient of a William Dawson Scholar award from McGill University. The funding sources had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JR received consulting fees for work unrelated to this study from Biogen. LA received consulting fees from Janssen and Pfizer for work unrelated to this study. HY, EGM, and AB have no conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study complied with the Declaration of Helsinki. The study protocol was approved by the Independent Scientific Advisory Committee of the CPRD (protocol number 20_000225R) and the Research Ethics Board of the Jewish General Hospital, Montreal, Canada (number 2021-2748).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors conceived and designed the study, interpreted the data, critically revised the manuscript for important intellectual content, and approved the final version of the manuscript. LA acquired the data. JR, HY, and LA conducted the analyses. JR drafted the manuscript. LA attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. LA is accountable for all aspects of the work.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"The data cannot be shared publicly due to the privacy policy of the Clinical Practice Research Datalink.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and code availability"}}]}}